The Food and Drug Administration announced on Oct. 15, 2026, that The Ritedose Corporation is recalling Formoterol Fumarate Inhalation Solution due to failed impurity specifications. Owners should contact the company for a refund.
How to tell if you have it
- Brand: Ritedose
- Product: Formoterol Fumarate Inhalation Solution, 20mcg/2mL
- NDC 76204-030-01 (cartons of 30 vials)
- NDC 76204-030-02 (cartons of 60 vials)
- Lot: 25BL0
- Expiration date: 02/28/2027
The hazard
The recall addresses failed impurity and degradation specifications in the inhalation solution. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show The Ritedose Corporation has two other recalls on record since April 1, 2022. Other recent recalls of similar products include Sun Pharmaceutical Fluocinolone Acetonide Solution Recall (Dec. 30, 2025), Novadoz Glycopyrrolate Oral Solution Recall (Dec. 15, 2025), and Cipla Recalls Fosfomycin Tromethamine Granules Due to Impurities (Sept. 18, 2026).